BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2697715)

  • 21. International Committee for Standardization in Haematology, International Committee on Thrombosis and Haemostasis: ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.
    Thromb Haemost; 1985 Feb; 53(1):155-6. PubMed ID: 3992515
    [No Abstract]   [Full Text] [Related]  

  • 22. [Home use of an ambulatory monitor for the determination of prothrombin time (coaguchek) in patients treated with oral anticoagulants. Multicenter prospective study].
    Cosmi B; Palareti G; Moia M; Pengo V; Testa S
    Minerva Cardioangiol; 1999 Dec; 47(12):598-9. PubMed ID: 10670221
    [No Abstract]   [Full Text] [Related]  

  • 23. Intensity of oral anticoagulation, continued.
    N Engl J Med; 1983 Sep; 309(13):794-5. PubMed ID: 6888459
    [No Abstract]   [Full Text] [Related]  

  • 24. [External quality control and standardization of prothrombin time determination for the monitoring of oral anticoagulant treatment in the Netherlands].
    van Duuk-Wierda CA; Loeliger EA; Roos J
    Ned Tijdschr Geneeskd; 1980 Jan; 124(4):103-7. PubMed ID: 7374832
    [No Abstract]   [Full Text] [Related]  

  • 25. The prothrombin time and monitoring oral anticoagulant therapy.
    Brownell A; Mackie IJ; Machin SJ
    Br J Hosp Med; 1986 Dec; 36(6):442-3. PubMed ID: 3801752
    [No Abstract]   [Full Text] [Related]  

  • 26. Rabbit (to replace human) brain material in anticoagulant control.
    Allington MJ; Bolton FG
    Lancet; 1986 May; 1(8489):1088. PubMed ID: 2871349
    [No Abstract]   [Full Text] [Related]  

  • 27. Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of.
    Tripodi A; Breukink-Engbers WG; van den Besselaar AM
    Semin Vasc Med; 2003 Aug; 3(3):243-54. PubMed ID: 15199457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Monitoring for oral anticoagulant therapy].
    Nakagawa K; Nakahara Y; Tsuji H
    Rinsho Ketsueki; 1995 Apr; 36(4):308-13. PubMed ID: 7783335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control.
    Loeliger EA; van den Besselaar AM; Lewis SM
    Thromb Haemost; 1985 Feb; 53(1):148-54. PubMed ID: 3992514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Monitoring treatment with oral anticoagulants in non-hospitalized patients].
    Gianotti A; Bottino G; Moscatelli P
    G Clin Med; 1987; 68(6-7):357-8. PubMed ID: 3653579
    [No Abstract]   [Full Text] [Related]  

  • 31. Control of oral anticoagulant therapy with whole blood prothrombin time devices: the future has begun.
    Tripodi A
    Thromb Haemost; 2000 Sep; 84(3):362-3. PubMed ID: 11019955
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin.
    van den Besselaar AM
    Thromb Haemost; 2000 Sep; 84(3):410-2. PubMed ID: 11019963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of a new chromogenic method for measuring prothrombin time in the control of oral anticoagulant therapy].
    Colla G; Corciulo G
    Boll Soc Ital Biol Sper; 1984 Nov; 60(11):2025-31. PubMed ID: 6525255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current biological surveillance of oral anticoagulant treatment].
    Helft G; Vacheron A; Samama MM
    Arch Mal Coeur Vaiss; 1995 Jan; 88(1):85-9. PubMed ID: 7646254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality control and oral anticoagulation.
    Preston FE
    Thromb Haemost; 1995 Jul; 74(1):515-20. PubMed ID: 8578516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [PT (INR) in extractive dental surgery in patients treated with oral anticoagulants].
    Caldarola F; Tealdi R; Molinatti M
    Minerva Stomatol; 1994 Apr; 43(4):167-9. PubMed ID: 8065287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral anticoagulants.
    Winter JH; Douglas AS
    Clin Haematol; 1981 Jun; 10(2):459-80. PubMed ID: 7032784
    [No Abstract]   [Full Text] [Related]  

  • 38. [Influence of the protein induced by vitamin K absence on thrombotest and hepaplastintest in the patients treated with oral anticoagulant].
    Murakami S; Muratani H; Kikuchi T; Fujimoto S; Hayashi T; Inai S; Imaoka S
    Rinsho Byori; 1983 Jan; 31(1):105-9. PubMed ID: 6865023
    [No Abstract]   [Full Text] [Related]  

  • 39. Laboratory monitoring of oral anticoagulant therapy: are we being misled?
    Albers GW
    Neurology; 1993 Mar; 43(3 Pt 1):468-70. PubMed ID: 8450985
    [No Abstract]   [Full Text] [Related]  

  • 40. Oral anticoagulant control.
    Lancet; 1987 Aug; 2(8557):488-9. PubMed ID: 2887782
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.